Seven Fleet Capital Management LP

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed June 4, 2026), Seven Fleet Capital Management LP reported 115 stock positions worth $318.3 million. Its top holding was CG Oncology at 30.6% of the portfolio, followed by Tango Therapeutics (TNGX, 3.3%) and Revolution Medicines (RVMD, 2.5%). Compared with Q4 2025, it opened 59 new positions, sold out of 29, added to 36 and reduced 17. The biggest buy was a new position in CG Oncology and the biggest sale CG Oncology (CGON, shares −95%).

Most Recent 13F
Q2 2026
Location
MOUNTAIN VIEW, CA
CIK
0002092021
Portfolio Value
$318.3M (Q1 2026)
SEC Filing
0001013594-26-000652 ↗ filed Jun 4, 2026

Holdings Value

0$200.0M$400.0M$600.0M$800.0M Q4 2025: $147.8M Q4 2025 Q1 2026: $318.3M $318.3M Q1 2026 Q2 2026: $605.9M Q2 2026

Holdings 115 stocks · $318.3M
CG ONCOLOGY INC 30.61% 1,439,393 $97.4M New
TNGX Tango Therapeutics Inc. 3.30% 502,012 $10.5M Add +133.3%
RVMD Revolution Medicines Inc. 2.47% 80,792 $7.9M Add +22.8%
TYRA Tyra Biosciences Inc. 2.35% 195,685 $7.5M Add +146.0%
LQDA Liquidia Corp. 2.23% 187,876 $7.1M Add +105.8%
AGIO Agios Pharmaceuticals Inc. 2.23% 209,547 $7.1M Add +560.2%
IPSC Century Therapeutics Inc. 2.09% 2,947,826 $6.7M New
ELVN Enliven Therapeutics Inc. 2.02% 164,030 $6.4M Add +64.1%
PCVX Vaxcyte Inc. 1.98% 108,450 $6.3M Add +327.6%
TANGO THERAPEUTICS INC 1.98% 300,648 $6.3M New
COGT Cogent Biosciences Inc. 1.81% 149,399 $5.8M Reduce -30.2%
AVALO THERAPEUTICS INC 1.69% 360,064 $5.4M New
MINERVA NEUROSCIENCES INC 1.68% 889,254 $5.4M New
CGON CG Oncology Inc. 1.61% 75,758 $5.1M Reduce -95.0%
PHVS Pharvaris NV 1.53% 172,731 $4.9M Add +212.1%
ABVX Abivax SA-ADR 1.51% 43,052 $4.8M Add +218.9%
DNTH Dianthus Therapeutics Inc. 1.43% 54,258 $4.6M Add +270.3%
PHARVARIS N V 1.28% 143,966 $4.1M New
CYTK Cytokinetics Inc. 1.27% 61,269 $4.0M Add +492.8%
SLNO Soleno Therapeutics Inc. 1.22% 115,770 $3.9M Reduce -11.0%
ENLIVEN THERAPEUTICS INC 1.17% 95,253 $3.7M New
ERAS Erasca Inc. 1.13% 222,468 $3.6M New
ROIV Roivant Sciences Ltd. 1.12% 128,168 $3.6M New
CYTOMX THERAPEUTICS INC. 1.05% 714,000 $3.4M New
AVTX Avalo Therapeutics Inc. 1.00% 213,819 $3.2M Add +237.6%
CENTURY THERAPEUTICS INC 0.99% 1,400,000 $3.2M New
EPRX Eupraxia Pharmaceuticals Inc. 0.99% 433,515 $3.1M New
IDYA Ideaya Biosciences Inc. 0.90% 86,283 $2.9M New
TSHA Taysha Gene Therapies Inc. 0.88% 625,708 $2.8M Add +274.2%
ASND Ascendis Pharma A/S 0.88% 12,179 $2.8M Add +114.8%
CMPX Compass Therapeutics Inc. 0.86% 516,972 $2.7M Reduce -9.1%
DMRA Damora Therapeutics Inc. 0.82% 101,248 $2.6M New
KALV Kalvista Pharmaceuticals Inc. 0.81% 128,487 $2.6M Add +165.4%
RLAY Relay Therapeutics Inc. 0.81% 257,738 $2.6M Add +253.1%
AXSM Axsome Therapeutics Inc. 0.75% 14,055 $2.4M Add +8.5%
COMPASS THERAPEUTICS INC 0.70% 423,566 $2.2M New
DIANTHUS THERAPEUTICS INC 0.70% 26,551 $2.2M New
EUPRAXIA PHARMACEUTICALS INC 0.63% 276,000 $2.0M New
DFTX Definium Therapeutics Inc. 0.59% 99,887 $1.9M New
MLYS Mineralys Therapeutics Inc. 0.59% 69,571 $1.9M Add +65.5%
SOLENO THERAPEUTICS INC 0.57% 54,000 $1.8M New
MDGL Madrigal Pharmaceuticals Inc. 0.56% 3,393 $1.8M Add +82.4%
CTMX Cytomx Therapeutics Inc. 0.55% 371,398 $1.7M Add +659.5%
LONA Leonabio Inc. 0.53% 164,676 $1.7M Add +28.7%
SVRA Savara Inc. 0.51% 295,688 $1.6M Add +371.1%
CATX Perspective Therapeutics Inc. 0.50% 379,082 $1.6M New
ASMB Assembly Biosciences Inc. 0.49% 56,147 $1.6M Reduce -23.9%
SAB BIOTHERAPEUTICS INC 0.48% 400,000 $1.5M New
NERV Minerva Neurosciences Inc. 0.47% 248,476 $1.5M New
ZLAB Zai Lab Ltd.-ADR 0.46% 77,858 $1.5M New
TARS Tarsus Pharmaceuticals Inc. 0.44% 19,800 $1.4M Add +340.0%
CRVS Corvus Pharmaceuticals Inc. 0.38% 82,890 $1.2M New
VAXCYTE INC 0.37% 20,000 $1.2M New
AVBP Arrivent Biopharma Inc. 0.36% 50,252 $1.2M New
LRMR Larimar Therapeutics Inc. 0.36% 256,585 $1.2M New
KRYS Krystal Biotech Inc. 0.35% 4,316 $1.1M Add +7.9%
IVA Inventiva SA - ADR 0.35% 200,141 $1.1M New
LPCN Lipocine Inc. 0.31% 124,942 $998K New
SYRE Spyre Therapeutics Inc. 0.31% 19,690 $993K New
BCRX Biocryst Pharmaceuticals Inc. 0.31% 102,493 $976K New
XNCR Xencor Inc. 0.30% 80,000 $965K Reduce -27.0%
CLDX Celldex Therapeutics Inc. 0.29% 29,300 $929K New
REPL Replimune Group Inc. 0.29% 120,400 $921K New
MAZE Maze Therapeutics Inc. 0.29% 30,707 $917K New
CLYM Climb Bio Inc. 0.28% 130,654 $895K Add +71.0%
CMPS Compass Pathways PLC 0.27% 158,021 $874K Add +295.1%
ALKS Alkermes PLC 0.27% 24,170 $855K New
SLN Silence Therapeutics PLC-ADR 0.26% 156,759 $826K Add +6.2%
CRBP Corbus Pharmaceuticals Holdi 0.25% 85,687 $805K Add +51.0%
CELC Celcuity Inc. 0.22% 6,000 $685K Reduce -28.0%
ANTX AN2 Therapeutics Inc. 0.21% 199,701 $683K New
DNLI Denali Therapeutics Inc. 0.21% 35,286 $677K New
UTHR United Therapeutics Corp. 0.21% 1,128 $669K Reduce -13.2%
LLY Eli Lilly & Co. 0.21% 720 $662K New
VSTM Verastem Inc. 0.21% 123,400 $654K Add +715.1%
LIQUIDIA CORPORATION 0.20% 17,000 $642K New
GERN Geron Corp. 0.20% 424,180 $632K Reduce -45.5%
IRD Opus Genetics Inc. 0.19% 134,242 $611K New
IKT Inhibikase Therapeutics Inc. 0.17% 325,600 $547K Reduce -39.0%
CNTX Context Therapeutics Inc. 0.16% 190,785 $500K New
DRUG Bright Minds Biosciences Inc. 0.15% 6,395 $467K New
VYGR Voyager Therapeutics Inc. 0.14% 115,203 $445K New
GPCR Structure Therapeutics Inc. 0.14% 9,000 $434K New
PTGX Protagonist Therapeutics Inc. 0.13% 4,000 $422K Reduce -50.0%
PRTA Prothena Corp. PLC 0.13% 43,300 $421K No change
NTLA Intellia Therapeutics Inc. 0.13% 31,500 $404K New
MIST Milestone Pharmaceuticals Inc. 0.12% 333,333 $397K New
SABS Sab Biotherapeutics Inc. 0.12% 100,000 $383K New
PALI Palisade Bio Inc. 0.12% 213,100 $373K Reduce -34.9%
GLUE Monte Rosa Therapeutics Inc. 0.12% 22,530 $371K Add +463.3%
EWTX Edgewise Therapeutics Inc. 0.12% 11,701 $369K Add +485.1%
UNCY Unicycive Therapeutics Inc. 0.12% 55,700 $367K New
CTNM Contineum Therapeutics Inc. Class A 0.11% 27,054 $353K New
TRVI Trevi Therapeutics Inc. 0.10% 27,149 $324K Add +281.8%
EOLS Evolus Inc. 0.10% 78,057 $321K Reduce -4.8%
NKTR Nektar Therapeutics 0.10% 4,300 $309K Reduce -71.3%
FULC Fulcrum Therapeutics Inc. 0.09% 38,100 $292K New
SEPN Septerna Inc. 0.09% 11,445 $275K No change
OCUL Ocular Therapeutix Inc. 0.08% 31,296 $265K Add +83.0%
ZNTL Zentalis Pharmaceuticals Inc. 0.08% 110,000 $257K New

Show all 115 holdings

Portfolio Sells Q4 2025 → Q1 2026
CGON CG Oncology Inc. Reduce -95.0% 1.61% −40.96
TERN Terns Pharmaceuticals Inc. Sold out 0.00% −3.57
COGT Cogent Biosciences Inc. Reduce -30.2% 1.81% −3.34
SLNO Soleno Therapeutics Inc. Reduce -11.0% 1.22% −2.86
EXEL Exelixis Inc. Sold out 0.00% −2.03
ASMB Assembly Biosciences Inc. Reduce -23.9% 0.49% −1.21
CMPX Compass Therapeutics Inc. Reduce -9.1% 0.86% −1.21
BLTE Belite Bio Inc. - ADR Sold out 0.00% −0.99
DYN Dyne Therapeutics Inc. Sold out 0.00% −0.93
XNCR Xencor Inc. Reduce -27.0% 0.30% −0.83
FOLD Amicus Therapeutics Inc. Sold out 0.00% −0.80
NUVL Nuvalent Inc. Class A Reduce -83.6% 0.07% −0.79
ZURA Zura Bio Ltd. Sold out 0.00% −0.59
IKT Inhibikase Therapeutics Inc. Reduce -39.0% 0.17% −0.57
PRAX Praxis Precision Medicines I Sold out 0.00% −0.54
RLMD Relmada Therapeutics Inc. Sold out 0.00% −0.50
GERN Geron Corp. Reduce -45.5% 0.20% −0.50
CDTX Cidara Therapeutics Inc. Sold out 0.00% −0.45
PALI Palisade Bio Inc. Reduce -34.9% 0.12% −0.40
MBX MBX Biosciences Inc. Sold out 0.00% −0.39
ZYME Zymeworks Inc. Sold out 0.00% −0.37
CELC Celcuity Inc. Reduce -28.0% 0.22% −0.35
PTGX Protagonist Therapeutics Inc. Reduce -50.0% 0.13% −0.34
NKTR Nektar Therapeutics Reduce -71.3% 0.10% −0.33
VRDN Viridian Therapeutics Inc. Sold out 0.00% −0.31
EOLS Evolus Inc. Reduce -4.8% 0.10% −0.27
NRIX Nurix Therapeutics Inc. Sold out 0.00% −0.26
PLRX Pliant Therapeutics Inc. Sold out 0.00% −0.23
ACRS Aclaris Therapeutics Inc. Sold out 0.00% −0.22
UTHR United Therapeutics Corp. Reduce -13.2% 0.21% −0.22
VKTX Viking Therapeutics Inc. Sold out 0.00% −0.14
QURE Uniqure NV Sold out 0.00% −0.14
BEAM Beam Therapeutics Inc. Reduce -7.7% 0.07% −0.11
ORKA Oruka Therapeutics Inc. Sold out 0.00% −0.11
NAMS Newamsterdam Pharma Co. NV Sold out 0.00% −0.10
ALXO Alx Oncology Holdings Inc. Sold out 0.00% −0.09
RGC Regencell Bioscience Holding Sold out 0.00% −0.06
IMUX Immunic Inc. Sold out 0.00% −0.06
TRAW Traws Pharma Inc. Sold out 0.00% −0.04
ATXS Astria Therapeutics Inc. Sold out 0.00% −0.04
VTGN Vistagen Therapeutics Inc. Sold out 0.00% −0.03
ENTA Enanta Pharmaceuticals Inc. Sold out 0.00% −0.02
GBIO Generation Bio Co. Sold out 0.00% −0.02
CGEM Cullinan Therapeutics Inc. Reduce -38.5% 0.01% −0.01
ELDN Eledon Pharmaceuticals Inc. Sold out 0.00% −0.01
VIR Vir Biotechnology Inc. Sold out 0.00% −0.00

Portfolio Buys Q4 2025 → Q1 2026
CG ONCOLOGY INC New 30.61% +30.61
IPSC Century Therapeutics Inc. New 2.09% +2.09
TNGX Tango Therapeutics Inc. Add +133.3% 3.30% +2.01
TANGO THERAPEUTICS INC New 1.98% +1.98
AVALO THERAPEUTICS INC New 1.69% +1.69
MINERVA NEUROSCIENCES INC New 1.68% +1.68
AGIO Agios Pharmaceuticals Inc. Add +560.2% 2.23% +1.64
PHARVARIS N V New 1.28% +1.28
PCVX Vaxcyte Inc. Add +327.6% 1.98% +1.19
ENLIVEN THERAPEUTICS INC New 1.17% +1.17
ERAS Erasca Inc. New 1.13% +1.13
ROIV Roivant Sciences Ltd. New 1.12% +1.12
CYTOMX THERAPEUTICS INC. New 1.05% +1.05
DNTH Dianthus Therapeutics Inc. Add +270.3% 1.43% +1.02
CENTURY THERAPEUTICS INC New 0.99% +0.99
EPRX Eupraxia Pharmaceuticals Inc. New 0.99% +0.99
ELVN Enliven Therapeutics Inc. Add +64.1% 2.02% +0.98
TYRA Tyra Biosciences Inc. Add +146.0% 2.35% +0.94
IDYA Ideaya Biosciences Inc. New 0.90% +0.90
CYTK Cytokinetics Inc. Add +492.8% 1.27% +0.82
DMRA Damora Therapeutics Inc. New 0.82% +0.82
COMPASS THERAPEUTICS INC New 0.70% +0.70
DIANTHUS THERAPEUTICS INC New 0.70% +0.70
EUPRAXIA PHARMACEUTICALS INC New 0.63% +0.63
DFTX Definium Therapeutics Inc. New 0.59% +0.59
SOLENO THERAPEUTICS INC New 0.57% +0.57
CATX Perspective Therapeutics Inc. New 0.50% +0.50
PHVS Pharvaris NV Add +212.1% 1.53% +0.49
SAB BIOTHERAPEUTICS INC New 0.48% +0.48
NERV Minerva Neurosciences Inc. New 0.47% +0.47
ZLAB Zai Lab Ltd.-ADR New 0.46% +0.46
CTMX Cytomx Therapeutics Inc. Add +659.5% 0.55% +0.41
RLAY Relay Therapeutics Inc. Add +253.1% 0.81% +0.39
CRVS Corvus Pharmaceuticals Inc. New 0.38% +0.38
VAXCYTE INC New 0.37% +0.37
AVBP Arrivent Biopharma Inc. New 0.36% +0.36
LRMR Larimar Therapeutics Inc. New 0.36% +0.36
IVA Inventiva SA - ADR New 0.35% +0.35
LPCN Lipocine Inc. New 0.31% +0.31
SYRE Spyre Therapeutics Inc. New 0.31% +0.31
BCRX Biocryst Pharmaceuticals Inc. New 0.31% +0.31
CLDX Celldex Therapeutics Inc. New 0.29% +0.29
REPL Replimune Group Inc. New 0.29% +0.29
MAZE Maze Therapeutics Inc. New 0.29% +0.29
KALV Kalvista Pharmaceuticals Inc. Add +165.4% 0.81% +0.28
ABVX Abivax SA-ADR Add +218.9% 1.51% +0.27
ALKS Alkermes PLC New 0.27% +0.27
TSHA Taysha Gene Therapies Inc. Add +274.2% 0.88% +0.26
SVRA Savara Inc. Add +371.1% 0.51% +0.25
AVTX Avalo Therapeutics Inc. Add +237.6% 1.00% +0.22

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 96$605.9MCGON, TNGX, RVMD, PHVS, LQDA
Q1 2026Amended 115$318.3MCG ONCOLOGY INC, TNGX, RVMD, TYRA, LQDA
Q4 2025Amended 85$147.8MCGON, COGT, SLNO, TERN, RVMD